Gleevec-Resistant Form of Kinase BCR-ABL

This is part of: Medicine in the Genomic Era


Mutations in the BCR-ABL gene can cause resistance to Gleevec, but another drug, dasatinib, can be used instead.

(Duration: 02 min 14 sec)
Launch This Resource
8 other people found this useful

By downloading, you agree to the permissions to use this file.